Chordate Medical Holding

Less than 1K followers

Overview

Investor consensus

All

Press releases

ShowingAll content types

Regulatory press release2/18/2026, 2:30 PM

Chordate’s application for delisting has been approved

Chordate Medical Holding

Regulatory press release2/18/2026, 12:25 PM

Chordate applies for delisting

Chordate Medical Holding

Regulatory press release1/16/2026, 7:40 AM

Chordate announces updated timetable for delisting

Chordate Medical Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release12/16/2025, 7:57 AM

Chordate Medical terminates the liquidity guarantee for the common share

Chordate Medical Holding

Regulatory press release12/8/2025, 3:30 PM

Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Regulatory press release11/18/2025, 6:40 PM

Notice to the Extraordinary General Meeting in Chordate Medical Holding AB (publ)

Chordate Medical Holding

Regulatory press release11/18/2025, 6:30 PM

The board of directors of Chordate proposes that the general meeting resolves on voluntary liquidation and delisting

Chordate Medical Holding

Regulatory press release8/21/2025, 6:30 AM

Chordate Announces Cost Reduction and Focus on Company Sale

Chordate Medical Holding

Press release8/19/2025, 6:30 AM

Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010

Chordate Medical Holding

Regulatory press release7/17/2025, 1:45 PM

Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Regulatory press release6/30/2025, 4:45 PM

Notice of Extraordinary General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Regulatory press release6/30/2025, 4:30 PM

Chordate decides on a conditional directed new issue of Preference Shares of approximately SEK 2.55 million

Chordate Medical Holding

Press release6/27/2025, 6:30 AM

Chordate presents conclusions from the second data monitoring of the ongoing open-label long-term study on chronic migraine: PM010

Chordate Medical Holding

Press release5/27/2025, 9:52 AM

BioStock: Chordate Medical’s CEO comments on the quarterly report

Chordate Medical Holding

Regulatory press release5/23/2025, 6:30 AM

Chordate Medical Holding AB (publ) Interim Report January-March 2025

Chordate Medical Holding

Regulatory press release5/21/2025, 2:15 PM

Communiqué from the Annual General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Press release5/20/2025, 9:00 AM

BioStock: BioStock: New distributor strengthens Chordate Medical’s investment in Saudi Arabia

Chordate Medical Holding

Press release5/13/2025, 8:45 AM

Chordate Medical Expands Migraine Offering in Saudi Arabia – Appoints Additional Distributor

Chordate Medical Holding

Regulatory press release5/7/2025, 8:55 AM

Chordate Medical terminates the liquidity provider agreement for the preference share

Chordate Medical Holding

Regulatory press release5/1/2025, 7:00 AM

Change of Certified Adviser (CA) to Bergs Securities

Chordate Medical Holding

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.